B-cell type non-Hodgkin’s lymphoma has a relatively higher cure rate.
Non-Hodgkin’s lymphoma can be categorized into T-cell non-Hodgkin’s lymphoma, B-cell non-Hodgkin’s lymphoma, and NK-cell non-Hodgkin’s lymphoma according to the type of lymphocytes.
The prognosis of different types of non-Hodgkin’s lymphoma varies. B-cell non-Hodgkin’s lymphoma is relatively curable, and among the B-cell non-Hodgkin’s lymphomas, follicular lymphoma and low-risk diffuse large B-cell lymphoma can be cured, with a cure rate of more than 50% in the early and middle stages. Nodular cell lymphomas, on the other hand, tend to be highly malignant and have a cure rate of less than 30%. Drugs include rituximab, vincristine, and adriamycin.
The survival rate of non-Hodgkin’s lymphoma is closely related to the patient’s age, type of pathology, complications, and the site and number of extra-lymph node involvement. The earlier the treatment, the higher the cure rate and the longer the survival time will be. It is recommended to go to the hospital in time and receive standardized treatment under the guidance of physicians.